Zdrowie i gospodarka · 04/12/2009
FDA Releases Draft Guidance for Immunogenicity Testing of Therapeutic Proteins
The Food and Drug Administration (FDA) has published a draft guidance document to help pharmaceutical companies develop accurate tests for detecting potential immune reactions to therapeutic proteins during clinical trials.
Source: Federal Register — Food and Drug AdministrationOpen original release →